Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucagon and GLP-1 co-agonists for the treatment of obesity

Glucagon and GLP-1 co-agonists for the treatment of obesity

US Patent 10676517 · Granted Jun 9, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polypeptides and uses thereof2025
Conjugates for targeting and clearing aggregates2024
Binding molecules specific for CD73 and uses thereof2022
Glucagon/GLP-1 agonists for the treatment of obesity2022
Conjugates for targeting and clearing aggregates2021
Antibodies to TGF-β2020
Glucagon/GLP-1 agonists for the treatment of obesity2020
Binding molecules specific for CD73 and uses thereof2020
Protease-resistant lipidated GLP-1 analogs2019
Binding molecules specific for CD73 and uses thereof2019
Blood brain barrier transport molecules and uses thereof2019
Antibodies to TGF-beta2019